Structural determinants of phosphodiesterase 6 response on binding catalytic site inhibitors

Neurochemistry International
Agnes SimonJulianna Kardos

Abstract

To predict the response of retinal phosphodiesterase on binding catalytic site inhibitors, a homology model of the catalytic domain of subunit alpha of type 6 phosphodiesterase has been built by selecting an experimental structure of type 5 phosphodiesterase as template. Guanosine monophosphate and inhibitors (sildenafil, zaprinast) docked to the type 6 phosphodiesterase binding crevice similarly to the experimental conformations of guanosine monophosphate and sildenafil in the catalytic domain of type 5 phosphodiesterase. Inhibitors, but not guanosine monophosphate, interacted with Phe778 and Met759 (sildenafil) or Met759 (zaprinast), the key residues involved in the interaction between the catalytic binding domain and the inhibitory gamma subunit of type 6 phosphodiesterase. Agreeing with predictions obtained by modelling binding, both inhibitors (1 and 10muM) enhanced the amplitude of electric light responses of the isolated rat retina, however, the enhancement was smaller for the more efficacious inhibitor sildenafil. These paradoxical responses can be explained as a result of the enhancement of light activation of PDE6 through the competition between the catalytic site inhibitors and the gamma subunit residues for catalyti...Continue Reading

References

Aug 11, 1990·The Journal of General Physiology·M C CornwallE F MacNichol
Sep 1, 1991·The Journal of General Physiology·W H Cobbs
Nov 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·M CapovillaV Torre
Oct 1, 1983·The Journal of Physiology·M CapovillaV Torre
Jan 23, 1996·Proceedings of the National Academy of Sciences of the United States of America·D Baylor
Jan 1, 1996·The Journal of General Physiology·A LyubarskyE N Pugh
May 2, 1997·The Journal of Biological Chemistry·A E GranovskyN O Artemyev
Sep 12, 1998·The Journal of Biological Chemistry·A E GranovskyN O Artemyev
May 13, 1999·The Journal of Biological Chemistry·J D Corbin, S H Francis
Apr 4, 2001·The Journal of Biological Chemistry·A E Granovsky, N O Artemyev
Jun 26, 2001·Progress in Brain Research·P WitkovskyD Tranchina
Jul 17, 2001·Journal of Molecular Biology·J F Kameni TcheudjiP Schultz
Sep 1, 2001·American Journal of Ophthalmology·J K LuuM F Marmor
Oct 18, 2001·Brain Research Bulletin·O Szabó-SalfayG Juhász
Dec 26, 2001·Trends in Endocrinology and Metabolism : TEM·Celine MehatsMarco Conti
Jan 10, 2002·Journal of Neuroscience Research·Péter BarabásArne Schousboe
Jun 28, 2002·Physiological Reviews·U Benjamin Kaupp, Reinhard Seifert
Sep 5, 2002·Progress in Retinal and Eye Research·Alan Laties, Eberhart Zrenner
Feb 13, 2003·Biochemistry·Philip L Yeagle, Arlene D Albert
Jun 25, 2003·Neurochemistry International·Péter BarabásJulianna Kardos
Jun 30, 2004·International Journal of Impotence Research·R H Cote
Jul 21, 2004·Molecular Cell·Kam Y J ZhangGideon Bollag
Aug 18, 2004·Neurochemistry International·Jos PrickaertsArjan Blokland
Apr 7, 2005·Biopolymers·Dongkyu ShinSeonggu Ro
Aug 16, 2005·Journal of Clinical Pharmacology·Manish GuptaBernd Meibohm
Sep 15, 2005·Clinical Cornerstone·Wallace W Dinsmore

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.